ABSTRACT
Clonación y construcción de un plásmido que codifica el gen del factor iniciador eucariótico de Leishmania de Leishmania major fundido con el gen de la proteína verde fluorescente como vacuna candidata (4, 5) . However, the emergence of resistance to the traditional antileishmanial compounds greatly reduces their efficiency (6) . In addition, treatment with alternative drugs and new formulations of old compounds are not suitable because of high toxic effects, resistance issues, excessive prices and long-term administration (7, 8) .
There are different vaccine candidates against leishmaniasis such as heat shock proteins (HSP), Leishmania eukaryotic initiation factor (LeIF), cysteine proteases, L major stress-inducible 1 (LmSTI1) etc (9) . Leishmania eukaryotic initiation factor is a prototype of the DEAD-box protein family that induces the production of interleukin (IL)-12, interferon gamma (IFN-ɤ), IL-10 and tumour necrosis factor-alpha (TNF-α) by macrophages and dendritic cells (10) . Both N-terminal and C-terminal parts of LeIF protein induce their production (11) . Green fluorescent protein (GFP) is derived from different organisms such as the jellyfish Aequorea victoria (12) and is used as a reporter of gene expression (13) . The protein intrinsically has fluorescent characteristics, while other fluorescent proteins need a cofactor. Also, GFP does not interfere with normal cell activities and does not have high toxicity (14) . Therefore, it has been used for gene expression measurement (14) . There are no efficient vaccines for leishmaniasis, therefore, development and production of an effective vaccine is necessary. The aim of this study was construction of a plasmid encoding LeIF protein into eukaryotic expression vector pEG-FP-N1 using it as a DNA vaccine candidate in the next studies.
METHODS

Culture of parasites
Leishmania major promastigotes (MRHO/IR/75/ER, Iranian strain) were cultivated at 26 °C in RPMI-1640 (Sigma) plus L-glutamine (20 mM), supplemented with 10% fetal bovine serum (FBS; Gibco), penicillin (100 U/mL) and streptomycin (100 µg/mL; Sigma).
Amplification of LeIF gene by polymerase chain reaction
Genomic DNA was extracted from the promastigote stage according to the procedure of Genomic DNA Extraction Kit (Bioneer, Korea). We used a pair of oligonucleotide based on the LeIF gene sequence obtained from GenBank [accession no. XM_003721551] (15). The full-length encoding sequence of LeIF was amplified (about 1212 bp) with PFU polymers to produce a blunt ended fragment by specific primers. Upstream primer contained a HindIII site (underlined) and downstream primer contained an EcoRI site (underlined) and without a stop codon (upstream: 5'-CAATTA AAGCTT ATG GCG CAG AAT GAT AAG ATC GCC-3' and downstream: 5'-CAT GGA ATT CCG CTT ACT CGC CAA GGT AGG CAG -3'). Polymerase chain reaction (PCR) amplification was performed using the following programme: initial denaturation at 95 °C for five minutes, denaturation at 95 °C for 1 minute, annealing at 48-54 °C for one minute, extension at 72 °C for one minute, 35 cycles and final extension at 72 °C for 10 minutes.
Cloning of LeIF gene into pJET1.2/blunt vector and transformation into E coli
The PCR product was recovered from agarose gel by Vivantis kit and was ligated into pJET1.2/blunt cloning vector (Fermentas) at 22 °C for 60 minutes; the ligation reaction product was transformed into Escherichia coli bacteria strain TOP10 by calcium chloride method. The transformed bacteria were cultured on Luria-Bertani agar media containing 100 µg/mL ampicillin and were incubated overnight at 37 °C. Cloning confirmation was done by two methods: colony PCR and sequencing, and then colonies containing recombinant plasmids were selected for subsequent works.
Subcloning of LeIF gene into eukaryotic expression plasmid pEGFP-N1
Recombinant plasmid was digested with EcoRI and HindIII enzymes (Fermentas) and the LeIF gene was recovered from agarose gel and was subcloned into the same restriction sites of the eukaryotic expression vector pEGFP-N1. The recombinant plasmid containing LeIF and enhanced GFP genes was purified by GF-1 Plasmid DNA Extraction Kit (Vivantis, Malaysia). Comparison of the recombinant pEGFP-LeIF and non-recombinant pEGFP-N1 plasmids, colony PCR and enzymatic analysis were confirmed subcloning.
RESULTS
DNA was extracted from
Leishmania promastigotes and assessed on 1% agarose gel. The LeIF gene was amplified by specific primers and PCR product showed a single band about 1212 bp. The PCR product was cloned into pJET1.2 blunt plasmid and the only bacteria containing inserted plasmids with LeIF gene grown on Luria-Bertani agar with 100 µg/mL ampicillin. Sequencing and colony PCR (Fig. 1) confirmed cloning. Sequencing results indicated 100% identity with Leishmania major strain Friedlin in GenBank (accession no. XM_003721551) and was submitted to GenBank with the accession number of KF752601. Colony PCR results demonstrated that the LeIF gene had been properly subcloned into eukaryotic expression vector pEGFP-N1. Also, the analysis of enzymatic restriction displayed that recombinant plasmid was digested by EcoRI and HindIII enzymes and was isolated in the LeIF gene (Fig. 2) . DISCUSSION DNA vaccines are bacterial plasmids encoding antigen whose release into living cells leads to expression of recombinant protein (16) . These plasmids were used for protective and therapeutic targets (17) . The vaccines are able to induce both humoral and cellular immune response against the encoded antigen. Because plasmid DNA contains CpG ODN sequences, it can also activate the innate immune response which results in up-regulation of co-stimulatory molecules, production of IL-12, and inflammatory cytokines and oxidant radicals by macrophages (18) . Proteins containing GFP can be directly detected in a living cell during real time using time lapse fluorescence microscopy. And it does not require fixing and staining cells with specific antibodies to the protein that may be fixed artefacts (12) . The LeIF stimulates production of proinflammatory cytokines such as IFN-ɤ by IL-12/IL-18-dependent mechanisms but it down-regulates production of IL-4 (10, 15) . Furthermore, LeIF induces generation of IL-2 and TNF-α and reduces production of IL-10 in peripheral blood mononuclear cells (10) .
In this study, the LeIF gene was cloned into pEGFP-N1 plasmid which contains cytomegalovirus promoter and is used as a powerful system for expression of recombinant proteins in eukaryotic cells. The cloned gene does not have a stop codon and will be expressed as a fusion protein that is located in the upstream of enhanced GFP gene. Enhanced green fluorescent protein fragment has a kozak sequence which enhances protein expression level; also, using GFP gene, the expression of this protein can be detected. According to the previous studies, LeIF antigen acts as a Th1-type natural adjuvant and stimulates Th1 response by IL-12 in the persons infected with Leishmania (9) . Leishmania eukaryotic initiation factor, in combination with other proteins or separately, is used as an antigen to construct a recombinant protein or a DNA vaccine. For example, LeIF is a part of a recombinant polyprotein vaccine, namely Leish-111f that protects against several species of Leishmania (19) . Finally, we made a recombinant plasmid encoding fusion of LeIF and GFP genes, which we can use for future studies, such as for a DNA vaccine.
